Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurokinin 3 receptor antagonist AZD4901 for menopausal hot flushes
2015-001553-32Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pavinetant in hot flash, sponsored by Imperial College London. Primary endpoint: Mean hot flush frequency per day. Started Jul 2015; status: completed.
02
Drugs
pavinetant
03
Conditions
hot flash
Beyond the preview
Go deeper on 2015-001553-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001553-32.